Recurrent coamplification of cystoskeleton-associated genes EMS1 and SHANK2 with CCND1 in oral squamous cell carcinoma

Genes Chromosomes and Cancer

Volumn 45, Issue 2, 2006, Pages 118-125

  Freier, Kolja ^a,b   Sticht, Carsten ^a,b   Hofele, Christof ^b   Flechtenmacher, Christa ^b   Stange, Daniel ^a   Puccio, Laura ^a,b   Toedt, Grischa ^a   Radlwimmer, Bernhard ^a   Lichter, Peter ^a   Joos, Stefan ^a  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^b UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN D1; CYTOSKELETON PROTEIN; MESSENGER RNA; CCND2 PROTEIN, HUMAN; CORTACTIN; CTTN PROTEIN, HUMAN; CYCLINE; NERVE PROTEIN; SHANK2 PROTEIN, HUMAN;

AMPLICON; ARTICLE; BACTERIAL ARTIFICIAL CHROMOSOME; CANCER GROWTH; CARCINOGENESIS; CCND1 GENE; CHROMOSOME 11Q; COMPARATIVE GENOMIC HYBRIDIZATION; CYTOSKELETON; DNA MICROARRAY; EMSI GENE; FLUORESCENCE IN SITU HYBRIDIZATION; GENE ACTIVATION; GENE AMPLIFICATION; GENE EXPRESSION; GENE FUNCTION; GENE OVEREXPRESSION; HUMAN; HUMAN TISSUE; MOUTH CARCINOMA; NUCLEOTIDE SEQUENCE; ONCOGENE; PRIORITY JOURNAL; PROTO ONCOGENE; SHANK2 GENE; SQUAMOUS CELL CARCINOMA; TISSUE MICROARRAY; UNINDEXED SEQUENCE; GENETICS; METABOLISM; MOUTH TUMOR; NUCLEIC ACID HYBRIDIZATION;

BACTERIA (MICROORGANISMS);

CARCINOMA, SQUAMOUS CELL; CHROMOSOMES, ARTIFICIAL, BACTERIAL; CORTACTIN; CYCLINS; CYTOSKELETON; GENE AMPLIFICATION; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; MOUTH NEOPLASMS; NERVE TISSUE PROTEINS; NUCLEIC ACID HYBRIDIZATION;

EID: 31944440018     PISSN: 10452257     EISSN: 10982264     Source Type: Journal    
DOI: 10.1002/gcc.20270     Document Type: Article

References (37)

1. Akervall J, Borg A, Dictor M, Jin C, Jin Y, Tanner M, Isola J, Mertens F, Wennerberg J. 2002. Chromosomal translocations involving 11q13 contribute to cyclin D1 overexpression in squamous cell carcinoma of the head and neck. Int J Oncol 20:45-52.
2. Akervall JA, Michalides RJ, Mineta H, Balm A, Borg A, Dictor MR, Jin Y, Loftus B, Mertens F, Wennerberg JP. 1997. Amplification of cyclin D1 in squamous cell carcinoma of the head and neck and the prognostic value of chromosomal abnormalities and cyclin D1 overexpression. Cancer 79:380-389.
3. Albertson DG, Ylstra B, Segraves R, Collins C, Dairkee SH, Kowbel D, Kuo WL, Gray JW, Pinkel D. 2000. Quantitative mapping of amplicon structure by array CGH identifies CYP24 as a candidate oncogene. Nat Genet 25:144-146.
4. Ashman JN, Patmore HS, Condon LT, Cawkwell L, Stafford ND, Greenman J. 2003. Prognostic value of genomic alterations in head and neck squamous cell carcinoma detected by comparative genomic hybridisation. Br J Cancer 89:864-869.
5. Bieche I, Olivi M, Nogues C, Vidaud M, Lidereau R. 2002. Prognostic value of CCND1 gene status in sporadic breast tumours, as determined by real-time quantitative PCR assays. Br J Cancer 86:580-586.
6. Bockmuhl U, Schluns K, Kuchler I, Petersen S, Petersen I. 2000. Genetic imbalances with impact on survival in head and neck cancer patients. Am J Pathol 157:369-375.
7. Boeckers TM, Bockmann J, Kreutz MR, Gundelfinger ED. 2002. ProSAP/Shank proteins-a family of higher order organizing molecules of the postsynaptic density with an emerging role in human neurological disease. J Neurochem 81:903-910.
8. Casiglia J, Woo SB. 2001. A comprehensive review of oral cancer. Gen Dent 49:72-82.
9. Dickson C, Peters G. 1987. Potential oncogene product related to growth factors. Nature 326:833.
10. Du Y, Weed SA, Xiong WC, Marshall TD, Parsons JT. 1998. Identification of a novel cortactin SH3 domain-binding protein and its localization to growth cones of cultured neurons. Mol Cell Biol 18:5838-5851.
11. Freier K, Joos S, Flechtenmacher C, Devens F, Benner A, Bosch FX, Lichter P, Hofele C. 2003. Tissue microarray analysis reveals site-specific prevalence of oncogene amplifications in head and neck squamous cell carcinoma. Cancer Res 63:1179-1182.
12. Garnis C, Coe BP, Zhang L, Rosin MP, Lam WL. 2004. Overexpression of LRP12, a gene contained within an 8q22 amplicon identified by high-resolution array CGH analysis of oral squamous cell carcinomas. Oncogene 23:2582-2586.
13. Holzmann K, Kohlhammer H, Schwaenen C, Wessendorf S, Kestler HA, Schwoerer A, Rau B, Radlwimmer B, Dohner H, Lichter P, Gress T, Bentz M. 2004. Genomic DNA-chip hybridization reveals a higher incidence of genomic amplifications in pancreatic cancer than conventional comparative genomic hybridization and leads to the identification of novel candidate genes. Cancer Res 64:4428-4433.
14. Huang X, Gollin SM, Raja S, Godfrey TE. 2002. High-resolution mapping of the 11q13 amplicon and identification of a gene, TAOS1, that is amplified and overexpressed in oral cancer cells. Proc Natl Acad Sci USA 99:11369-11374.
15. Jemal A, Murray T, Samuels A, Ghafoor A, Ward E, Thun MJ. 2003. Cancer statistics, 2003. CA Cancer J Clin 53:5-26.
16. Korz C, Pscherer A, Benner A, Mertens D, Schaffner C, Leupolt E, Dohner H, Stilgenbauer S, Lichter P. 2002. Evidence for distinct pathomechanisms in B-cell chronic lymphocytic leukemia and mantle cell lymphoma by quantitative expression analysis of cell cycle and apoptosis-associated genes. Blood 99:4554-4561.
17. Lambros MB, Fiegler H, Jones A, Gorman P, Roylance RR, Carter NP, Tomlinson IP. 2005. Analysis of ovarian cancer cell lines using array-based comparative genomic hybridization. J Pathol 205:29-40.
18. McWilliams RR, Gidey E, Fouassier L, Weed SA, Doctor RB. 2004. Characterization of an ankyrin repeat-containing Shank2 isoform (Shank2E) in liver epithelial cells. Biochem J 380:181-191.
19. Mineta H, Miura K, Takebayashi S, Ueda Y, Misawa K, Harada H, Wennerberg J, Dictor M. 2000. Cyclin D1 overexpression correlates with poor prognosis in patients with tongue squamous cell carcinoma. Oral Oncol 36:194-198.
20. Namazie A, Alavi S, Olopade OI, Pauletti G, Aghamohammadi N, Aghamohammadi M, Gornbein JA, Calcaterra TC, Slamon DJ, Wang MB, Srivatsan ES. 2002. Cyclin D1 amplification and p16(MTS1/CDK4I) deletion correlate with poor prognosis in head and neck tumors. Laryngoscope 112:472-481.
21. Ormandy CJ, Musgrove EA, Hui R, Daly RJ, Sutherland RL. 2003. Cyclin D1, EMS1 and 11q13 amplification in breast cancer. Breast Cancer Res Treat 78:323-335.
22. Patel AM, Incognito LS, Schechter GL, Wasilenko WJ, Somers KD. 1996. Amplification and expression of EMS-1 (cortactin) in head and neck squamous cell carcinoma cell lines. Oncogene 12:31-35.
23. Patel AS, Schechter GL, Wasilenko WJ, Somers KD. 1998. Overexpression of EMS1/cortactin in NIH3T3 fibroblasts causes increased cell motility and invasion in vitro. Oncogene 16:3227-3232.
24. Rodrigo JP, Garcia LA, Ramos S, Lazo PS, Suarez C. 2000. EMS1 gene amplification correlates with poor prognosis in squamous cell carcinomas of the head and neck. Clin Cancer Res 6:3177-3182.
25. Schraml P, Schwerdtfeger G, Burkhalter F, Raggi A, Schmidt D, Ruffalo T, King W, Wilber K, Mihatsch MJ, Moch H. 2003. Combined array comparative genomic hybridization and tissue microarray analysis suggest PAK1 at 11q13.5-q14 as a critical oncogene target in ovarian carcinoma. Am J Pathol 163:985-992.
26. Schwaenen C, Nessling M, Wessendorf S, Salvi T, Wrobel G, Radlwimmer B, Kestler HA, Haslinger C, Stilgenbauer S, Dohner H, Bentz M, Lichter P. 2004. Automated array-based genomic profiling in chronic lymphocytic leukemia: development of a clinical tool and discovery of recurrent genomic alterations. Proc Natl Acad Sci USA 101:1039-1044.
27. Solinas-Toldo S, Lampel S, Stilgenbauer S, Nickolenko J, Benner A, Dohner H, Cremer T, Lichter P. 1997. Matrix-based comparative genomic hybridization: biochips to screen for genomic imbalances. Genes Chromosomes Cancer 20:399-407.
28. Sticht C, Hofele C, Flechtenmacher C, Bosch FX, Freier K, Lichter P, Joos S. 2005. Amplification of cyclin L1 is associated with lymph node metastases in head and neck squamous cell carcinoma (HNSCC). Br J Cancer 92:770-774.
29. Tankere F, Camproux A, Barry B, Guedon C, Depondt J, Gehanno P. 2000. Prognostic value of lymph node involvement in oral cancers: a study of 137 cases. Laryngoscope 110:2061-2065.
30. Veltman JA, Fridlyand J, Pejavar S, Olshen AB, Korkola JE, DeVries S, Carroll P, Kuo WL, Pinkel D, Albertson D, Cordon-Cardo C, Jain AN, Waldman FM. 2003. Array-based comparative genomic hybridization for genome-wide screening of DNA copy number in bladder tumors. Cancer Res 63:2872-2880.
31. Weber RG, Scheer M, Born IA, Joos S, Cobbers JM, Hofele C, Reifenberger G, Zoller JE, Lichter P. 1998. Recurrent chromosomal imbalances detected in biopsy material from oral premalignant and malignant lesions by combined tissue microdissection, universal DNA amplification, and comparative genomic hybridization. Am J Pathol 153:295-303.
32. Weiss MM, Snijders AM, Kuipers EJ, Ylstra B, Pinkel D, Meuwissen SG, van Diest PJ, Albertson DG, Meijer GA. 2003. Determination of amplicon boundaries at 20q13.2 in tissue samples of human gastric adenocarcinomas by high-resolution microarray comparative genomic hybridization. J Pathol 200:320-326.
33. Wessendorf S, Schwaenen C, Kohlhammer H, Kienle D, Wrobel G, Barth TF, Nessling M, Moller P, Dohner H, Lichter P, Bentz M. 2003. Hidden gene amplifications in aggressive B-cell non-Hodgkin lymphomas detected by microarray-based comparative genomic hybridization. Oncogene 22:1425-1429.
34. Yu Z, Weinberger PM, Haffty BG, Sasaki C, Zerillo C, Joe J, Kowalski D, Dziura J, Camp RL, Rimm DL, Psyrri A. 2005. Cyclin d1 is a valuable prognostic marker in oropharyngeal squamous cell carcinoma. Clin Cancer Res 11:1160-1166.
35. Zafarana G, Grygalewicz B, Gillis AJ, Vissers LE, van de Vliet W, van Gurp RJ, Stoop H, Debiec-Rychter M, Oosterhuis JW, van Kessel AG, Schoenmakers EF, Looijenga LH, Veltman JA. 2003. 12p-amplicon structure analysis in testicular germ cell tumors of adolescents and adults by array CGH. Oncogene 22:7695-7701.
36. Zaharieva BM, Simon R, Diener PA, Ackermann D, Maurer R, Alund G, Knonagel H, Rist M, Wilber K, Hering F, Schonenberger A, Flury R, Jager P, Fehr JL, Mihatsch MJ, Gasser T, Sauter G, Toncheva DI. 2003. High-throughput tissue microarray analysis of 11q13 gene amplification (CCND1, FGF3, FGF4, EMS1) in urinary bladder cancer. J Pathol 201:603-608.
37. Zielinski B, Gratias S, Toedt G, Mendrzyk F, Stange DE, Radlwimmer B, Lohmann DR, Lichter P. 2005. Detection of chromosomal imbalances in retinoblastoma by matrix-based comparative genomic hybridization. Genes Chromosomes Cancer 43:294-301.